newsfilter
← Latest News
GlobeNewswire·

Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO) today announced the closing of its previously announced underwritten public offering of 87,500,000 shares of its